Colgate-Palmolive Company (CL) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CL Revenue Growth
Revenue Breakdown (FY 2025)
CL's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CL Revenue Analysis (2014–2025)
As of May 6, 2026, Colgate-Palmolive Company (CL) generated trailing twelve-month (TTM) revenue of $20.38 billion, reflecting solid growth of +5.8% year-over-year. The most recent quarter (Q4 2025) recorded $5.23 billion in revenue, up 1.9% sequentially.
Looking at the longer-term picture, CL's 5-year compound annual growth rate (CAGR) stands at +4.4%, indicating moderate growth over time. The company achieved its highest annual revenue of $20.38 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows CL's business is primarily driven by Oral, Personal and Home Care (77%), and Pet Nutrition (23%). With over half of revenue concentrated in Oral, Personal and Home Care, the company maintains significant focus in this area while developing other growth vectors.
When compared to Consumer Defensive sector peers including PG (+3.3% YoY), UL (+2.5% YoY), and KMB (-8.8% YoY), CL has outperformed the peer group in terms of revenue growth. Compare CL vs PG →
CL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLCurrent | $20.4B | +5.8% | +4.4% | 21.3% | |
 PG | $84.3B | +3.3% | +3.5% | 24.3% | |
 UL | $60.8B | +2.5% | +3.2% | 15.5% | |
 KMB | $17.2B | -8.8% | -2.1% | 14.5% | |
 CHD | $6.2B | +2.2% | +4.8% | 17.4% | |
 ENR | $3.0B | +2.7% | +1.5% | 17.8% |
CL Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $20.38B | +1.4% | $12.25B | 60.1% | $4.35B | 21.3% |
| 2024 | $20.10B | +3.3% | $12.11B | 60.2% | $4.38B | 21.8% |
| 2023 | $19.46B | +8.3% | $11.25B | 57.8% | $4.13B | 21.2% |
| 2022 | $17.97B | +3.1% | $10.15B | 56.5% | $3.58B | 20.0% |
| 2021 | $17.42B | +5.8% | $10.29B | 59.1% | $3.89B | 22.3% |
| 2020 | $16.47B | +5.0% | $9.93B | 60.3% | $3.91B | 23.7% |
| 2019 | $15.69B | +1.0% | $9.28B | 59.1% | $3.76B | 24.0% |
| 2018 | $15.54B | +0.6% | $9.21B | 59.2% | $3.85B | 24.8% |
| 2017 | $15.45B | +1.7% | $9.32B | 60.3% | $4.01B | 25.9% |
| 2016 | $15.20B | -5.2% | $9.13B | 60.1% | $3.96B | 26.1% |
Full CL Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CL vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonCL — Frequently Asked Questions
Quick answers to the most common questions about buying CL stock.
Is CL's revenue growth accelerating or slowing?
CL maintains +5.8% revenue growth, in line with its 5-year CAGR of +4.4%. TTM revenue stands at $20.4B. Growth rate remains consistent with historical average.
What is CL's long-term revenue growth rate?
Colgate-Palmolive Company's 5-year revenue CAGR of +4.4% reflects the sustained expansion pattern. Current YoY growth of +5.8% is near this long-term average.
How is CL's revenue distributed by segment?
CL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.